Zytoprotec Competitors and Similar CompaniesClear all
Zytoprotec's competitors and similar companies include OriGene Technologies, BioCryst Pharmaceuticals, Boston Analytical and Bioiberica.
 Zytoprotec Zytoprotec is a life science company that develops drugs using a cytoprotection therapeutic approach. |  BioCryst Pharmaceuticals BioCryst Pharmaceuticals designs, optimizes and develops novel small-molecule drugs that block key enzymes to treat rare diseases. |  Boston Analytical Boston Analytical is a company that provides analytical testing services to support CMC for drug development and release testing. |  Bioiberica Bioiberica is a life science company engaged in the identification, extraction, and development of animal-derived biomolecules. | ||
Founding Date | Founding Date 2007 | Founding Date 1996 | Founding Date 1986 | Founding Date 1987 | Founding Date 1975 |
Type | Type Private | Type Subsidiary | Type Public | Type Subsidiary | Type Subsidiary |
Tags | |||||
Locations | Locations Wien, AT HQ | Locations Rockville, US HQ Herford, DE Newark, US Windham, US | Locations Durham, US HQ Hoover, US | Locations Salem, US HQ | Locations Esplugues de Llobregat, ES HQ Barcelona, ES Palafolls, ES |
Employees | Employees N/A | Employees 1242% increase | Employees 14040% increase | Employees 2441% decrease | Employees 332 |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $874.8m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $346.7m (FY, 2018) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods $19.1m (FY, 2025) | Cost of goods N/A | Cost of goods $190.3m (FY, 2018) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit $855.8m (FY, 2025) | Gross profit N/A | Gross profit $156.4m (FY, 2018) |
Net income | Net income N/A | Net income N/A | Net income $263.9m (FY, 2025) | Net income N/A | Net income $40.5m (FY, 2018) |
Funding | |||||
Total funding raised | Total funding raised $ 2.7m | Total funding raised $ 69.6m | Total funding raised $ 1.9m | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
OriGene Technologies
HQ
Rockville, US
OriGene Technologies is a company specializing in biotechnology research.
View companyBioCryst Pharmaceuticals
HQ
Durham, US
Employees
140↑ 40% increase
BioCryst Pharmaceuticals designs, optimizes and develops novel small-molecule drugs that block key enzymes to treat rare diseases.
View companyBoston Analytical
HQ
Salem, US
Boston Analytical is a company that provides analytical testing services to support CMC for drug development and release testing.
View companyBioiberica
HQ
Esplugues de Llobregat, ES
Bioiberica is a life science company engaged in the identification, extraction, and development of animal-derived biomolecules.
View company